跳到主要內容

Bradbury Daniel 的 Form 4 申報

Castle Biosciences Inc(CSTL),2024/1/8 申報

申報編號
0001447362-24-000008
申報時間
2024/1/8
交易日
2024/1/4-1/5
申報延遲
4 天
10b5-1 計畫
有勾選

這份申報列了 6 筆非衍生性交易。公開市場賣出合計 $47.6 萬。交易後 4 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Bradbury DanielCIK 0001236397董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2024/1/4Common StockS賣出處分−5,776$20.40F2−$117,830.466,312間接
2024/1/4Common StockS賣出處分−6,222$20.40F2−$126,928.843,574間接
2024/1/4Common StockS賣出處分−6,225$20.40F2−$126,99043,591間接
2024/1/5Common StockS賣出處分−1,617$20.36F6−$32,922.1264,695間接
2024/1/5Common StockS賣出處分−1,741$20.36F6−$35,446.7641,833間接
2024/1/5Common StockS賣出處分−1,742$20.36F6−$35,467.1241,849間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

This transaction was executed in multiple trades at prices ranging from $20.23 to $20.83, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 3 筆交易的價格引用這則附註。

F6

This transaction was executed in multiple trades at prices ranging from $20.05 to $20.62, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 3 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)